A top Eli Lilly (LLY.N), opens new tab executive said on Monday that more patients are paying the full list price of its obesity drug Zepbound than those who had paid for its predecessor Mounjaro.Patrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman…[#item_full_content]
Harris Fails to Move Swing States After Debate
Vice President Kamala Harris has failed to make a dent in swing state polls following the Sept. 10 presidential debate, according to an analysis from